Patients with melanoma and who are being treated with PD-1 inhibitors have an increased risk of experiencing immune-related neurologic adverse events, compared with patients who are not being treated with...
Individuals with acute hepatic porphyria often experience acute attacks and chronic symptoms which greatly diminish their quality of life. Researchers examined the efficacy of givosiran in reducing these...
Researchers investigated whether survivors of stroke could take two common types of antidepressant medications—SSRIs and SNRIs—and evaluated if serious bleeding occurred among patients. Their findings were...
A diverse team of experts representing the National Association of Epilepsy Centers updated a set of guidelines and recommendations for the care of patients with epilepsy.
The FDA approved the first treatment for patients with congenital thrombotic thrombocytopenic purpura (cTTP), which is a rare and life-threatening blood clotting disorder that may be fatal if left...
